10-Q
NABI BIOPHARMACEUTICALS 9/27/2003
- Company
- Vaxart, Inc.
- Filed
- October 27, 2003
- Period of Report
- September 27, 2003
- Accession Number
- 0000950144-03-011806
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →